Vimta Labs Limited (NSE:VIMTALABS) — Market Cap & Net Worth
Market Cap & Net Worth: Vimta Labs Limited (VIMTALABS)
Vimta Labs Limited (NSE:VIMTALABS) has a market capitalization of $297.70 Million (Rs27.53 Billion) as of September 16, 2026. Listed on the NSE stock exchange, this India-based company holds position #14936 globally and #749 in its home market, demonstrating a -3.09% decrease in market value over the past year.
Market capitalization, also known as net worth in stock markets, is calculated by multiplying Vimta Labs Limited's stock price Rs616.00 by its total outstanding shares 44686904 (44.69 Million). Also see Vimta Labs Limited total assets for a full breakdown of the balance sheet.
Vimta Labs Limited Market Cap History: 2015 to 2026
Vimta Labs Limited's market capitalization history from 2015 to 2026. Data shows growth from $46.99 Million to $297.70 Million (20.89% CAGR). Also see VIMTALABS cash flow metrics for how efficiently the company converts equity into cash flow.
Vimta Labs Limited Market Cap to Earnings & Revenue Ratios Timeline
This chart shows how Vimta Labs Limited's valuation ratios have evolved. The Price to Sales (P/S) ratio compares market cap to revenue, while the Price to Earnings (P/E) ratio compares market cap to net income. Lower values may indicate a more undervalued company relative to its financial performance. Check Vimta Labs Limited (VIMTALABS) share price today for real-time trading data and today's change.
Latest Price to Sales (P/S) Ratio
0.07x
Vimta Labs Limited's market cap is 0.07 times its annual revenue
Latest Price to Earnings (P/E) Ratio
0.38x
Vimta Labs Limited's market cap is 0.38 times its annual earnings
What These Ratios Tell Investors:
- Price to Sales (P/S) Ratio: Shows how much investors are paying for each dollar of the company's sales. Lower P/S ratios may indicate undervaluation.
- Price to Earnings (P/E) Ratio: Shows how much investors are paying for each dollar of the company's earnings. This is one of the most common valuation metrics.
- Trends in these ratios over time can indicate changing investor sentiment about the company's future growth prospects.
- Industry comparison provides context for whether the company is valued higher or lower than peers.
| Year | Market Cap (USD) | Revenue (USD) | Net Income (USD) | P/S Ratio | P/E Ratio |
|---|---|---|---|---|---|
| 2017 | $77.77 Million | $1.54 Billion | $105.92 Million | 0.05x | 0.73x |
| 2018 | $146.52 Million | $1.83 Billion | $164.33 Million | 0.08x | 0.89x |
| 2019 | $43.81 Million | $2.13 Billion | $253.11 Million | 0.02x | 0.17x |
| 2020 | $82.18 Million | $1.81 Billion | $68.45 Million | 0.05x | 1.20x |
| 2021 | $194.74 Million | $2.09 Billion | $214.05 Million | 0.09x | 0.91x |
| 2022 | $209.06 Million | $2.76 Billion | $413.30 Million | 0.08x | 0.51x |
| 2023 | $194.26 Million | $3.15 Billion | $481.72 Million | 0.06x | 0.40x |
| 2024 | $480.44 Million | $3.18 Billion | $410.09 Million | 0.15x | 1.17x |
| 2025 | $292.52 Million | $3.44 Billion | $673.42 Million | 0.09x | 0.43x |
| 2026 | $297.70 Million | $4.07 Billion | $775.12 Million | 0.07x | 0.38x |
Competitor Companies of VIMTALABS by Market Capitalization
Companies near Vimta Labs Limited in the global market cap rankings as of September 16, 2026. Review Vimta Labs Limited (VIMTALABS) tangible equity ratio to assess the quality of the company's equity after excluding intangible assets.
Key companies related to Vimta Labs Limited by market ranking:
- Thermo Fisher Scientific Inc (NYSE:TMO): Ranked #88 globally with a market cap of $224.59 Billion USD.
- Danaher Corporation (NYSE:DHR): Ranked #161 globally with a market cap of $147.88 Billion USD.
- WuXi AppTec Co Ltd (SHG:603259): Ranked #476 globally with a market cap of $56.70 Billion USD ( CN¥387.49 Billion CNY).
- Natera Inc (NASDAQ:NTRA): Ranked #578 globally with a market cap of $47.01 Billion USD.
| Rank | Company | Symbol | Market Cap | Price |
|---|---|---|---|---|
| #88 | Thermo Fisher Scientific Inc | NYSE:TMO | $224.59 Billion | $641.39 |
| #161 | Danaher Corporation | NYSE:DHR | $147.88 Billion | $209.36 |
| #476 | WuXi AppTec Co Ltd | SHG:603259 | $56.70 Billion | CN¥156.67 |
| #578 | Natera Inc | NASDAQ:NTRA | $47.01 Billion | $350.78 |
Vimta Labs Limited Historical Marketcap From 2015 to 2026
Between 2015 and today, Vimta Labs Limited's market cap moved from $46.99 Million to $ 297.70 Million, with a yearly change of 20.89%.
| Year | Market Cap | Change (%) |
|---|---|---|
| 2026 | Rs297.70 Million | +1.77% |
| 2025 | Rs292.52 Million | -39.11% |
| 2024 | Rs480.44 Million | +147.32% |
| 2023 | Rs194.26 Million | -7.08% |
| 2022 | Rs209.06 Million | +7.35% |
| 2021 | Rs194.74 Million | +136.96% |
| 2020 | Rs82.18 Million | +87.60% |
| 2019 | Rs43.81 Million | -70.10% |
| 2018 | Rs146.52 Million | +88.40% |
| 2017 | Rs77.77 Million | +61.93% |
| 2016 | Rs48.03 Million | +2.22% |
| 2015 | Rs46.99 Million | -- |
End of Day Market Cap According to Different Sources
On Sep 16th, 2026 the market cap of Vimta Labs Limited was reported to be:
| Source | Market Cap |
|---|---|
| Yahoo Finance | $297.70 Million USD |
| MoneyControl | $297.70 Million USD |
| MarketWatch | $297.70 Million USD |
| marketcap.company | $297.70 Million USD |
| Reuters | $297.70 Million USD |
Market cap values may vary slightly between sources due to differences in calculation methods, timing, and data refresh rates.
About Vimta Labs Limited
Vimta Labs Limited provides contract research and testing services in India and internationally. The company offers drug discovery, development, and drug life cycle management support services in the areas of preclinical research, clinical research, and analytical services for biopharmaceutical companies; preclinical research and testing services for medical device companies; and contract researc… Read more